The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Mehmet Sofuoglu

School of Medicine

Department of Psychiatry

VA Connecticut Healthcare System

Yale University

USA

[email]@yale.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • School of Medicine, Department of Psychiatry, VA Connecticut Healthcare System, Yale University, USA. 2003 - 2013
  • Department of Psychiatry, University of Minnesota, Minneapolis, USA. 2002 - 2003

References

  1. Cognitive enhancement as a treatment for drug addictions. Sofuoglu, M., Devito, E.E., Waters, A.J., Carroll, K.M. Neuropharmacology (2013) [Pubmed]
  2. Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report. Sofuoglu, M., Herman, A.I., Li, Y., Waters, A.J. Psychopharmacology (Berl.) (2012) [Pubmed]
  3. The reinforcement threshold for nicotine as a target for tobacco control. Sofuoglu, M., LeSage, M.G. Drug. Alcohol. Depend (2012) [Pubmed]
  4. Commentary on Ling et al. (2012): The PROMETA™ treatment does not reduce methamphetamine use. Sofuoglu, M. Addiction (2012) [Pubmed]
  5. Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers. Sofuoglu, M., Mouratidis, M., Mooney, M. Psychoneuroendocrinology (2011) [Pubmed]
  6. Galantamine improves sustained attention in chronic cocaine users. Sofuoglu, M., Waters, A.J., Poling, J., Carroll, K.M. Exp. Clin. Psychopharmacol (2011) [Pubmed]
  7. Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans. Sofuoglu, M., Mooney, M., Kosten, T., Waters, A., Hashimoto, K. Psychopharmacology (Berl.) (2011) [Pubmed]
  8. Cognitive enhancement as a pharmacotherapy target for stimulant addiction. Sofuoglu, M. Addiction (2010) [Pubmed]
  9. Cognitive function as an emerging treatment target for marijuana addiction. Sofuoglu, M., Sugarman, D.E., Carroll, K.M. Exp. Clin. Psychopharmacol (2010) [Pubmed]
  10. Atomoxetine attenuates dextroamphetamine effects in humans. Sofuoglu, M., Poling, J., Hill, K., Kosten, T. Am. J. Drug. Alcohol. Abuse (2009) [Pubmed]
  11. Subjective responses to intravenous nicotine: greater sensitivity in women than in men. Sofuoglu, M., Mooney, M. Exp. Clin. Psychopharmacol (2009) [Pubmed]
  12. Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans. Sofuoglu, M., Waters, A.J., Mooney, M., O'Malley, S.S. Pharmacol. Biochem. Behav. (2009) [Pubmed]
  13. Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans. Sofuoglu, M., Herman, A.I., Mooney, M., Waters, A.J. Psychopharmacology (Berl.) (2009) [Pubmed]
  14. Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers. Sofuoglu, M., Mitchell, E., Mooney, M. Hum. Psychopharmacol (2009) [Pubmed]
  15. Cholinergic functioning in stimulant addiction: implications for medications development. Sofuoglu, M., Mooney, M. CNS. Drugs (2009) [Pubmed]
  16. Norepinephrine and stimulant addiction. Sofuoglu, M., Sewell, R.A. Addict. Biol (2009) [Pubmed]
  17. Riluzole and D-amphetamine interactions in humans. Sofuoglu, M., Waters, A.J., Mooney, M., Kosten, T. Prog. Neuropsychopharmacol. Biol. Psychiatry (2008) [Pubmed]
  18. Disulfiram enhances subjective effects of dextroamphetamine in humans. Sofuoglu, M., Poling, J., Waters, A., Sewell, A., Hill, K., Kosten, T. Pharmacol. Biochem. Behav. (2008) [Pubmed]
  19. Self-administration of intravenous nicotine in male and female cigarette smokers. Sofuoglu, M., Yoo, S., Hill, K.P., Mooney, M. Neuropsychopharmacology (2008) [Pubmed]
  20. Modafinil and nicotine interactions in abstinent smokers. Sofuoglu, M., Waters, A.J., Mooney, M. Hum. Psychopharmacol (2008) [Pubmed]
  21. Progesterone effects on cocaine use in male cocaine users maintained on methadone: a randomized, double-blind, pilot study. Sofuoglu, M., Poling, J., Gonzalez, G., Gonsai, K., Oliveto, A., Kosten, T.R. Exp. Clin. Psychopharmacol (2007) [Pubmed]
  22. Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers. Sofuoglu, M., Poling, J., Mouratidis, M., Kosten, T. Psychopharmacology (Berl.) (2006) [Pubmed]
  23. Emerging pharmacological strategies in the fight against cocaine addiction. Sofuoglu, M., Kosten, T.R. Expert. Opin. Emerg. Drugs (2006) [Pubmed]
  24. Adrenergic blocker carvedilol attenuates the cardiovascular and aversive effects of nicotine in abstinent smokers. Sofuoglu, M., Mouratidis, M., Yoo, S., Kosten, T. Behav. Pharmacol (2006) [Pubmed]
  25. Cocaine withdrawal symptoms predict medication response in cocaine users. Sofuoglu, M., Poling, J., Gonzalez, G., Gonsai, K., Kosten, T. Am. J. Drug. Alcohol. Abuse (2006) [Pubmed]
  26. The effect of individual cocaine withdrawal symptoms on outcomes in cocaine users. Sofuoglu, M., Dudish-Poulsen, S., Poling, J., Mooney, M., Hatsukami, D.K. Addict. Behav (2005) [Pubmed]
  27. Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers. Sofuoglu, M., Mouratidis, M., Yoo, S., Culligan, K., Kosten, T. Psychopharmacology (Berl.) (2005) [Pubmed]
  28. Tiagabine affects the subjective responses to cocaine in humans. Sofuoglu, M., Poling, J., Mitchell, E., Kosten, T.R. Pharmacol. Biochem. Behav. (2005) [Pubmed]
  29. Effects of progesterone treatment on cocaine responses in male and female cocaine users. Sofuoglu, M., Mitchell, E., Kosten, T.R. Pharmacol. Biochem. Behav. (2004) [Pubmed]
  30. Pharmacologic management of relapse prevention in addictive disorders. Sofuoglu, M., Kosten, T.R. Psychiatr. Clin. North Am. (2004) [Pubmed]
  31. Association of cocaine withdrawal symptoms with more severe dependence and enhanced subjective response to cocaine. Sofuoglu, M., Dudish-Poulsen, S., Brown, S.B., Hatsukami, D.K. Drug. Alcohol. Depend (2003) [Pubmed]
  32. Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans. Sofuoglu, M., Singha, A., Kosten, T.R., McCance-Katz, F.E., Petrakis, I., Oliveto, A. Pharmacol. Biochem. Behav. (2003) [Pubmed]
  33. Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokers. Sofuoglu, M., Babb, D., Hatsukami, D.K. Nicotine Tob. Res. (2003) [Pubmed]
  34. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence. Sofuoglu, M., Gonzalez, G., Poling, J., Kosten, T.R. Am. J. Drug. Alcohol. Abuse (2003) [Pubmed]
  35. Effects of progesterone treatment on smoked cocaine response in women. Sofuoglu, M., Babb, D.A., Hatsukami, D.K. Pharmacol. Biochem. Behav. (2002) [Pubmed]
 
WikiGenes - Universities